NR4A1 and breast carcinoma: Although summary-level BCAC data stratified by age are currently not available for the five hormone receptor subtypes that we studied, new summary-level data have been calculated by Dr. Kyriaki Michailidou for ER+ and ER− breast cancer across three age categories (<40, 40–55, and >55 years).